The US Department of Justice (DOJ) on Tuesday charged Israeli generic drug giant Teva Pharmaceutical Industries Ltd with illegally fixing prices between 2013 and 2015.
Teva and several coconspirators “agreed to fix prices, rig bids and allocate customers for generic drugs,” including the popular cholesterol-regulating medicine Pravastatin, the department said in a statement.
Patients would have paid a total of US$350 million more than they should have, it said.
Photo: Reuters
Rejecting the charges, Teva said it was “deeply disappointed that the [US] government has chosen to proceed with this prosecution.”
Efforts to find a solution had made no progress as “the DOJ has shown an unwillingness to consider alternatives that would not deeply impact Teva and the stakeholders who depend on the company, including the patients who benefit from our medicines,” Teva said in a statement.
Five companies investigated in the case have already paid heavy fines to avoid prosecution.
Sandoz, a subsidiary of the Swiss pharmaceutical giant Novartis AG, agreed to pay US$195 million in March, and the US subsidiary of the Israeli group Taro Pharmaceuticals Industries Ltd last month agreed to pay US$205.7 million.
Other companies involved include Apotex Inc, which agreed to pay a US$24.1 million fine in May, and Glenmark Pharmaceuticals Ltd, which was indicted by a grand jury last month.
Teva, which sold US$17 billion of drugs last year, was also accused earlier this month by US authorities of artificially inflating the reimbursement price for its multiple-sclerosis drug Copaxone for patients in the government-run Medicare program.
Separately, Sepehr Sarshar, the former founder and chief executive of Auspex Pharmaceuticals Inc, was on Tuesday arrested in California on insider trading charges, accused of feeding secrets that enabled friends and family to earn more than US$700,000 illegally.
Sepehr, 53, of Encinitas, California, was charged in Manhattan federal court with securities fraud, wire fraud and fraud in connection with a tender offer.
He was released on US$1 million bail after an initial appearance in San Diego federal court.
Authorities said he provided inside information in 2015 about a pending US$3.2 billion buyout offer from Teva to his friends and family so they could trade securities in Auspex.
Additional reporting by AP
JITTERS: Nexperia has a 20 percent market share for chips powering simpler features such as window controls, and changing supply chains could take years European carmakers are looking into ways to scratch components made with parts from China, spooked by deepening geopolitical spats playing out through chipmaker Nexperia BV and Beijing’s export controls on rare earths. To protect operations from trade ructions, several automakers are pushing major suppliers to find permanent alternatives to Chinese semiconductors, people familiar with the matter said. The industry is considering broader changes to its supply chain to adapt to shifting geopolitics, Europe’s main suppliers lobby CLEPA head Matthias Zink said. “We had some indications already — questions like: ‘How can you supply me without this dependency on China?’” Zink, who also
The number of Taiwanese working in the US rose to a record high of 137,000 last year, driven largely by Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) rapid overseas expansion, according to government data released yesterday. A total of 666,000 Taiwanese nationals were employed abroad last year, an increase of 45,000 from 2023 and the highest level since the COVID-19 pandemic, data from the Directorate-General of Budget, Accounting and Statistics (DGBAS) showed. Overseas employment had steadily increased between 2009 and 2019, peaking at 739,000, before plunging to 319,000 in 2021 amid US-China trade tensions, global supply chain shifts, reshoring by Taiwanese companies and
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) received about NT$147 billion (US$4.71 billion) in subsidies from the US, Japanese, German and Chinese governments over the past two years for its global expansion. Financial data compiled by the world’s largest contract chipmaker showed the company secured NT$4.77 billion in subsidies from the governments in the third quarter, bringing the total for the first three quarters of the year to about NT$71.9 billion. Along with the NT$75.16 billion in financial aid TSMC received last year, the chipmaker obtained NT$147 billion in subsidies in almost two years, the data showed. The subsidies received by its subsidiaries —
At least US$50 million for the freedom of an Emirati sheikh: That is the king’s ransom paid two weeks ago to militants linked to al-Qaeda who are pushing to topple the Malian government and impose Islamic law. Alongside a crippling fuel blockade, the Group for the Support of Islam and Muslims (JNIM) has made kidnapping wealthy foreigners for a ransom a pillar of its strategy of “economic jihad.” Its goal: Oust the junta, which has struggled to contain Mali’s decade-long insurgency since taking power following back-to-back coups in 2020 and 2021, by scaring away investors and paralyzing the west African country’s economy.
RSS